Optoseeker Biotech has reached a major milestone with two groundbreaking research papers led by its co-founder, published in the world-renowned academic journals ACS Nano and Analytical Chemistry. These studies, powered by the OptoBot®500 Optoelectronic Tweezer System and the DropletBot® Digital Microfluidic Platform, successfully address critical industry challenges in exosome enrichment and nanoplastics detection in biological fluids. This achievement underscores the company’s independent innovation and the significant industrial potential of high-end life science instrumentation.
1. Optoelectronic "Nanograspers": A 10-Second Breakthrough in Serum-Based Trace Detection
The study published in ACS Nano introduces an Optoelectronic Tweezer (OET)-assisted "nanograsper" system designed to detect trace macromolecules and particles in complex biological fluids.
- From Passive Waiting to Active Enrichment: Traditional SERS detection relies on slow natural diffusion. This platform achieves true "active enrichment" by using fluidic vortices to pull distant targets into the detection zone, shattering the physical bottleneck of diffusion limits.
- Rapid Response: The total time for substrate preparation and detection is compressed from hours to just 10 seconds.
- High Sensitivity and Stability: The system achieved a limit of detection (LOD) of $4.43 \times 10^{-8}$ M for Rhodamine B, with a batch-to-batch relative standard deviation (RSD) as low as 6.89%, meeting the rigorous standards for commercial SERS substrates.
- Clinical Potential: Capable of direct detection in serum without complex pre-treatment, this technology offers a high-value pathway for next-generation Point-of-Care Testing (POCT) and high-throughput screening.
- System Support:
This research relied on the OptoBot®500 Optoelectronic Tweezer System, which integrates high-precision DMD structured light and flexible electric field control for precise micro-nano manipulation.
2. Exosome Lipid Profiling: Accelerating Analysis from 2 Hours to 15 Minutes
Published in Analytical Chemistry, this research presents an automated, miniaturized "assembly line" for the enrichment and "unboxing" of extracellular vesicles (EVs, including exosomes).
- Efficiency Revolution: Traditional ultracentrifugation is time-consuming and risks damaging vesicle activity. By treating droplets as programmable "chess pieces," this platform compresses the total time for EV enrichment and lipid extraction from over 2 hours to just 15 minutes.
- High Recovery & Fidelity: For rare samples ($<2.5$ μL), the platform achieves a 78% recovery rate while maintaining high biological activity—significantly outperforming traditional methods.
- Application in Immuno-Metabolism: The technology successfully mapped the lipid remodeling of macrophage polarization (M0 vs. M2), providing vital molecular evidence for disease diagnosis and therapeutic research.
- System Support:
This study utilized technology consistent with the DropletBot® Digital Microfluidic Platform, which uses Electrowetting-on-Dielectric (EWOD) to achieve nanoliter-scale precision in droplet control.
Strategic Vision: Leading the Future of Life Science Tools
These breakthroughs highlight the versatility of Optoseeker Biotech’s core technology. By replacing complex mechanical valves with non-contact optoelectronic and physical mechanisms, these platforms are poised to transform high-value sectors, including antibody drug development, rare cell sorting, and synthetic biology.
Optoseeker Biotech remains committed to innovation, providing global researchers with the advanced "heavy weaponry" needed to solve cutting-edge challenges and driving the evolution of high-end scientific instruments.
References:
- Light-Programmable Nanograspers for Rapid Nanoplastics Detection in Biological Fluids.
https://doi.org/10.1021/acsnano.5c20989
- Streamlined Digital Microfluidics-Mass Spectrometry Strategy for Extracellular Vesicle Enrichment and Lipid Profiling.
https://doi.org/10.1021/acs.analchem.5c07527
